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not become more efficient. With the
telogen-to-anagen length ratio now
altered in favor of telogen, there is a
much larger proportion of telogen hair
follicles at any given time. Thus, the
human scalp skin appears bald because
scalp follicles do not retain old hair shafts
efficiently as compared with mouse
pelage follicles. An attractive method for
anti–hair-loss therapy would be reactivat-
ing the coupling between scalp hair
follicles (reviewed in Plikus et al., 2011)
so that rare spontaneous activation events
can spread, increasing the overall number
of follicles in anagen. An alternative
method would be counteracting intra-
follicular telogen refractivity, and in this
respect Fgf18 and TGF-b signaling emerge
as potential targets. For example, further
inquiries into the Fgf18-Fgfr3/4 pathway
are encouraged by the fact that Fgf18 is
indeed elevated in the epithelial progeni-
tor cells of human hair follicles (Garza
et al., 2011). In addition, soluble Fgfr3/4
extracellular domain fragments promote
hair growth in mice upon local and sys-
temic delivery (Brennan et al., 2011a,b).
In summary, Kimura-Ueki et al. (2012)
and Oshimori and Fuchs (2012) add Fgf18
and Tgf-b2 firmly to the list of crucial hair
cycle clock regulators. Future studies
should aim to establish details of how
the BMP, WNT, FGF, TGF-b, and other
signaling pathways jointly regulate
refractory telogen, competent telogen,
and telogen-to-anagen initiation events
within each hair follicle stem cell niche
and throughout the skin (Figure 1).
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Building Models for Keratin Disorders
Maranke I. Koster1
Palmoplantar keratoderma is a hallmark of pachyonychia congenita (PC) and focal
non-epidermolytic palmoplantar keratoderma (FNEPPK). By generating keratin 16
(Krt16)–deficient mice, Lessard and Coulombe, as described in this issue, have
generated a mouse model to replicate these palmoplantar lesions. Studies using
this model may provide novel insights into the molecular mechanisms responsible
for the formation of palmoplantar lesions in PC and FNEPPK patients.
Journal of Investigative Dermatology (2012) 132, 1324–1326. doi:10.1038/jid.2012.58
The keratin 16 gene (KRT16 (human)/Krt16
(mouse)) encodes an intermediate filament
protein that is normally expressed in pal-
moplantar epidermis, tongue epithelia, hair
follicles, and nail bed epithelia. Dominant
mutations in KRT16 are responsible for
two inherited disorders: pachyonychia
congenita (PC) and focal non-epidermoly-
tic palmoplantar keratoderma (FNEPPK).
Patients affected by these disorders suffer
from extensive palmoplantar keratoderma,
leading to the formation of painful and
debilitating calluses, primarily on their
soles. In addition, PC patients develop
dystrophic nails, hair abnormalities, and
oral leukokeratosis, which are features not
associated with FNEPPK. As in other
inherited disorders caused by keratin muta-
tions, the mutant KRT16 proteins produced
in PC and FNEPPK are believed to func-
tion, at least in part, by destabilizing the
existing intermediate filament network
within cells, leading to cell fragility. Fur-
ther, as keratins have also been implicated
in cell signaling, mutant keratin proteins
may also affect other cellular processes,
such as proliferation and apoptosis.
Although the mutations underlying PC
and FNEPPK are known, the molecular
mechanisms leading to the clinical features
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associated with these disorders are not
well understood. Thus, it is important to
develop models that genetically and phe-
notypically model the disorders, allowing
for a detailed characterization of the
pathological mechanisms responsible for
them. By altering the expression of genes
associated with PC, including Krt6a, Krt6b,
and Krt17, several mouse models have
been generated in which the oral, nail,
and/or hair abnormalities are replicated
(Wong et al., 2000, 2005; Wojcik et al.,
2001; McGowan et al., 2002; Chen et al.,
2007). Surprisingly, none of these mouse
models has exhibited palmoplantar kerato-
derma, and no genetically relevant mouse
models mimicking the palmoplantar
lesions have been reported previously. In
this issue, Lessard and Coulombe report on
the generation of a Krt16-deficient mouse
model that reproduces the palmoplantar
lesions that develop in patients with PC
and FNEPPK. Further, they propose a
novel mechanism explaining the pre-
sence of hair, nail, and skin abnormalities
in PC patients with KRT16 mutations.
The Krt16-null mice generated by Les-
sard and Coulombe (2012) were found to
develop two major problems. First,
although born at Mendelian ratios, Krt16-
null mice had a reduced birth weight, and
their early postnatal survival was compro-
mised. Strikingly, well over half of the
Krt16-null mice died before weaning age.
This early postnatal mortality is explained,
in part, by hyperplastic lesions that develop
on the posterior tongue. Such lesions were
first observed in mice deficient for both
Krt6a and Krt6b (Wong et al., 2000;
Wojcik et al., 2001), and they have been
suggested to lead to feeding difficulties and
consequent failure to thrive. Although the
oral lesions provide a possible explanation
for poor postnatal survival, the cause and
consequences of the low birth weight of
Krt16-null mice were not investigated.
Given that keratins have been found to
have critical roles in several different
signaling cascades, it is possible that aber-
rant cell signaling, perhaps leading to
abnormalities in proliferation, may have
led to a reduction in the body weight of
the Krt16-null newborn mice. It remains
unclear whether, independent of the oral
lesions, the low birth weight may have
contributed to early postnatal lethality. In
addition to the failure to thrive, surviving
adult Krt16-null mice developed promi-
nent calluses on the pressure points of their
paws. These calluses compromised the
animals’ mobility, suggesting that, as in
PC and FNEPPK, these lesions were asso-
ciated with pain. The cause of the pain in
humans remains a matter of speculation,
but it may be associated with blister
formation below the calluses and/or
secondary infection due to extensive
cracking of the callused epidermis.
The findings reported by Lessard and
Coulombe (2012) indicate that expression
of mutant KRT16 proteins, as observed in
PC and FNEPPK patients, and a complete
absence of KRT16, as engineered in the
mouse model, lead to similar conse-
quences in the palmoplantar epidermis.
In both cases, Krt16/KRT16 abnormalities
cause the formation of calluses on areas
prone to mechanical stress. Comparable
phenotypic consequences of mutant
keratin expression versus absent keratin
expression have also been observed for
other keratins, including KRT14 and
KRT10, where null or dominant mutations
lead to epidermolysis bullosa simplex or
epidermolytic hyperkeratosis, respecti-
vely (Chamcheu et al., 2011). However,
whereas null mutations in KRT14 or
KRT10 have been described in humans,
this is not the case for KRT16. A possible
explanation for this would be that, in
humans, a null mutation in KRT16 leads
to a premature termination of pregnancy
due to its requirement in tissues other than
the skin and skin appendages.
Interestingly, even though Krt16-null
mice develop the plantar keratoderma that
is characteristic of PC, they do not develop
other characteristics of PC, including nail
dystrophy. The phenotype of the Krt16-null
mice is therefore more reminiscent of
FNEPPK than of PC. The underlying reason
for the differences in the affected tissues of
FNEPPK and PC patients is not known, but
some information has been obtained
by analyzing mutant KRT16 proteins
expressed in either FNEPPK or PC (Smith
et al., 2000). Interestingly, in this study,
mutant KRT16 proteins expressed in
FNEPPK were found to be less capable of
contributing to intermediate filaments than
those expressed in PC. Further, the partial
exclusion of these mutant KRT16 proteins
from the intermediate filament network
led to a diminished destabilizing effect on
the intermediate filament network. Thus,
Lessard and Coulombe (2012) speculate
that destabilization of the intermediate
filament network may be less critical for
the development of palmoplantar kerato-
derma than it is for the development of
nail dystrophy. However, it remains to be
determined whether partial exclusion from
the filament network represents a general
mechanism for mutant KRT16 proteins
expressed in FNEPPK. In addition, given
that Krt16 heterozygous mice do not deve-
lop palmoplantar keratoderma, haplo-
insufficiency is unlikely to be the sole
mechanism underlying callus form-
ation in FNEPPK or PC.
Another possible explanation for the
differences in the affected tissues between
FNEPPK and PC is related to the role of
keratins in cellular processes other than
structure. In fact, it has recently become
clear that the functions of keratins extend
beyond their roles as structural proteins.
Among other processes, keratins have now
been implicated in the control of trans-
lation, apoptosis, cell cycle progression,
and tumor susceptibility (Koch and Roop,
2004; Karantza, 2011). Thus, mutant
KRT16 proteins expressed in FNEPPK and
PC may affect cellular signaling pathways
differently, thereby leading to cell-context–
dependent changes in cellular behavior.
In this respect, it would be of interest to
compare the gene expression profiles of
cells expressing PC- or FNEPPK-specific
mutant KRT16 proteins to determine the
transcriptional consequences associated
with the expression of these proteins.
Clinical Implications
 Keratin 16–deficient mice develop palmoplantar keratoderma.
 The palmoplantar lesions that develop in pachyonychia congenita
and focal non-epidermolytic palmoplantar keratoderma are
mimicked in this mouse model.
 The molecular mechanisms underlying the formation of palmoplantar
keratoderma may be a combination of effects on structural stability
and aberrant cell signaling.
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In summary, although a complete
understanding of the mechanisms leading
to palmoplantar keratoderma and nail
dystrophy in PC has yet to be achieved,
Krt16-null mice provide additional insights
into this process and highlight the impor-
tance of KRT16 in the normal structure
and function of palmoplantar epithelia.
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IL-33: A Novel Danger Signal System in
Atopic Dermatitis
Ferda Cevikbas1 and Martin Steinhoff1
IL-33 is a newly recognized cytokine of the IL-1 cytokine family that has recently been
attributed to the epithelial ‘‘alarmin’’ defense system. IL-33 is released by the epithelial
cells in various tissues and organs, including keratinocytes, endothelial cells, and
immune cells. Recent reports have suggested that IL-33 might be a critical part of the
innate immunity, although its precise role is as yet poorly understood. In several organs,
IL-33 appears to drive T helper type 2 (Th2) responses, suggesting roles in allergic and
atopic diseases, as well as in fibrosis. IL-33 exerts its effects by activating the ST2
(suppression of tumorigenicity 2)/IL-1 aR receptor on different types of cells, including
mast cells and Th2 cells. The ST2 receptor is either expressed on the cell surface or shed
from these cells (soluble ST2, sST2), thereby functioning as a ‘‘decoy’’ receptor. After
binding to its receptor, IL-33 activates NF-kB, suggesting that it regulates the outcome of
diseases such as atopic dermatitis. On the other hand, several studies have reported on
the inhibitory effects of sST2 in inflammatory and fibrotic diseases, suggesting that IL-33/
ST2 is a unique cytokine with potential pro- and anti-inflammatory effects.
Journal of Investigative Dermatology (2012) 132, 1326–1329. doi:10.1038/jid.2012.66
Atopic dermatitis (AD) is a common
chronic inflammatory skin disease char-
acterized by an early T helper type 2
(Th2) ‘‘immune signature’’: patients suffer
from relapsing eczematous and occasion-
ally generalized (erythroderma) lesions
associated with severe pruritus (Bonness
and Bieber, 2007; Boguniewicz and
Leung, 2011). Scratching reactions to
pruritus typically exacerbate the inflam-
matory skin reactions (Hong et al., 2011).
The key events in AD may be subdivided
as an interplay among (1) infiltrating
immune cells (Th2 cells and—later—
Th1 cells, macrophages, dendritic cells,
mast cells, and eosinophils); (2) skin-
resident keratinocytes and endothelial
cells; and (3) activated (‘‘hypersensitive’’)
peripheral sensory nerves. The multicel-
lular action is believed to orchestrate
disease onset and progression (Steinhoff
et al., 2006; Cevikbas et al., 2007). Un-
fortunately, current AD treatments, which
suppress inflammation broadly (e.g.,
steroids, cyclosporin A), are hampered
by effects on other cells and pathways
that are unrelated to the disease.
The adaptive and innate immune sys-
tems have important and bidirectional
roles in the pathophysiology of AD
(Bieber, 2008; Elias and Steinhoff, 2008).
Cytokines such as IL-4 and IL-13 regulate
proinflammatory responses of the adap-
tive immune response in early phases of
AD by regulating Th2 activation; thus,
they are considered optimal targets for
therapies. Keratinocytes, however, as part
of the innate immune defense, also
contribute to the inflammatory reactions
and immune responses in AD by regu-
lating the release of cytokines, chemo-
kines, proteases, and bioactive lipids.
Upon stimulation by allergens, toxins,
or infectious agents, keratinocytes are
capable of initiating a cross-talk bet-
ween the adaptive and innate immune
responses by activating T cells in
patients with AD through the release of
key molecules (Homey et al., 2006).
Thus, cytokines such as IL-25 and
chemokines such as TSLP (thymic
stromal lymphopoietin) or CCL27 have
important roles in this interactive net-
work (Carmi-Levy et al., 2011).
Recent evidence points to a role for
the IL-33/ST2 (suppression of tumorigeni-
city 2) pathway in epithelial integrity,
allergic immune responses, inflamma-
tion, autoimmunity, and fibrosis, which
are just several examples (Moussion
et al., 2008; Ivanov et al., 2010; Rankin
et al., 2010). In skin, the functional role
of this newly recognized IL-33/ST2
pathway has gained attention. The
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